New PhRMA Report: Nearly 300 Vaccines Currently in Development

Today, the Pharmaceutical Research and Manufacturers of America released a report, Medicines in Development: Vaccines – A Report on the Prevention and Treatment of Disease Through Vaccines. The report shows that U.S. biopharma companies are currently developing 271 vaccines to prevent and treat numerous conditions, including infectious diseases and various forms of cancer and neurological disorders.

Vaccines have successfully prevented devastating infectious diseases such as smallpox, measles and polio. According to data from the Centers for Disease Control and Prevention (CDC), 10 infectious diseases have been at least 90 percent eradicated in the U.S. as a result of vaccines. These innovations and subsequent immunization efforts have protected millions of children and families.

“Biopharmaceutical research companies are working with partners across the ecosystem to apply new scientific approaches to the development of both preventative and therapeutic vaccines,” said PhRMA President and CEO John J. Castellani. “The nearly 300 vaccines in the pipeline provide great hope for protecting and improving public health in the United States and across the globe.”

For more on the latest news and developments in the biopharma industry, please visit http://phrma.org.

Health  |  Email This Post  |  Printer Friendly
Tags: , , , ,

One Response to New PhRMA Report: Nearly 300 Vaccines Currently in Development

  1. Tracy,

    did the report give the number or % of vaccines that were cell culture media based vs. egg based?

    Cheers,
    Prof Frank
    President & Laboratory Director
    AminoAcids.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>